Nagesh Mhatre

Dr. Nagesh S.
Mhatre is a Member at The Angels' Forum LLC and a Principal at The Halo Funds.
Prior to joining the Halo Fund III Management Company, Dr. Mhatre has served in the initial development phases as Chairman and CEO (interim) of several startup companies: NuGenesis Technologies Corp., a company that developed and marketed data warehousing and data mining for pharmaceutical research groups; MicroSure, Inc., a medical device company; Strategic Solutions Group, an e-learning company, specializing in systems solutions for training and service for large corporations and US government agencies and Metrika, Inc., a developer of medical diagnostic technologies.
Historically, he also served on the boards of Quidel Corporation, a medical diagnostic company, and NitroMed, Inc., a nitric oxide delivery systems for cardiac stenosis company.
Dr. Mhatre was founding Chairman of Guava Technologies, Inc. which developed a flow metric system that is the first Personal Cytometer (Guava- PCA) for quantization in the bioanalytical field in human and veterinary sciences.
Currently, he serves as founding Chairman of BioImagene Corp, which recently acquired Scimagix, Inc., which he also founded.
He served as Executive Chairman of Alpha Innotech Corp., which provides integrated systems tools for functional genomics.
He initiated two new startups – Cytoplex Biosciences, Inc., which explores chip technology for cell physiology, and Vista Biosciences, LLC, a developer of a novel continuous glucose monitoring system.
Dr. Mhatre received his BS degree from Bombay University, India, an MS degree from Oregon State University and a PhD degree in biochemistry/microbiology from Rutgers University, New Brunswick, N.J.